ADAM17 and its proteolytic targets in disease pathogenesis
ADAM17 as a multifunctional sheddase with contrasting roles across inflammatory, metabolic, cardiovascular, and neoplastic diseases. Through regulated activation by iRhom, iTAP/FRMD8, and tetraspanins, ADAM17 cleaves diverse membrane ligands and receptors, thereby promoting inflammation, fibrosis, obesity, insulin resistance, and tumor progression ...
Abdulbasit Amin, Marina Badenes
wiley +1 more source
Mitochondria can be transferred from bone marrow cells to cancer cells in acute myeloid leukaemia and multiple myeloma, boosting tumour energy production, growth, and drug resistance. This review highlights key transfer mechanisms and shows how targeting mitochondrial movement and dynamics may offer new therapeutic strategies to limit cancer ...
Ebubechukwu Nwarunma +1 more
wiley +1 more source
Knocking down CLDN7 enhanced the effect of cisplatin in OC cells by regulating mitophagy. [PDF]
Zheng X +5 more
europepmc +1 more source
Reversing Bladder Cancer Chemo-resistance through Blocking Cell Senescence by a Combination Therapy. [PDF]
He Y +11 more
europepmc +1 more source
Acquired resistance of cancer therapies: Mechanisms and perspectives. [PDF]
Wang M +8 more
europepmc +1 more source
Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer. [PDF]
Zhou H +9 more
europepmc +1 more source
Unraveling glutamine metabolism in ovarian carcinoma: signaling cross-talk, positron emission tomography utility, and therapeutic boundaries. [PDF]
Tong J.
europepmc +1 more source
SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research. [PDF]
Kong X +6 more
europepmc +1 more source

